SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decrease of about -34.82% in the sales to Rs. 4076.00 millions was observed for the quarter ended December 2024. The sales stood at Rs. 6253.00 millions during the similar quarter previous year.Net Profit of the company move down -34.95% to Rs. 1249.00  millions from Rs. 1920.00 millions  in the same quarter last year.A decline of 1974.00 millions was observed in the OP in the quarter ended December 2024 from 2678.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4076.00 6253.00 -34.82 29371.00 26041.00 12.79 35689.00 23510.00 51.80
Other Income 1680.00 295.00 469.49 2592.00 688.00 276.74 1047.00 855.00 22.46
PBIDT 1974.00 2678.00 -26.29 18423.00 12531.00 47.02 17417.00 9302.00 87.24
Interest 34.00 38.00 -10.53 108.00 100.00 8.00 145.00 86.00 68.60
PBDT 1940.00 2640.00 -26.52 18315.00 12431.00 47.33 17272.00 9216.00 87.41
Depreciation 437.00 404.00 8.17 1263.00 1203.00 4.99 1719.00 1509.00 13.92
PBT 1503.00 2236.00 -32.78 17052.00 11228.00 51.87 15553.00 7707.00 101.80
TAX 254.00 316.00 -19.62 2829.00 1653.00 71.14 2487.00 1336.00 86.15
Deferred Tax -25.00 -105.00 -76.19 -252.00 -359.00 -29.81 -361.00 5.00 -7320.00
PAT 1249.00 1920.00 -34.95 14223.00 9575.00 48.54 13066.00 6371.00 105.09
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 365.00 -1.92
PBIDTM(%) 48.43 42.83 13.08 62.73 48.12 30.35 48.80 39.57 23.34

Natco Pharma Share Price

1174.00 19.80 (1.72%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×